Shock: Clinical Trials

2,234 trials for Shock, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1037 completed, 468 unknown, 280 recruiting, 158 terminated. 602 Not applicable, 295 Phase 2, 232 Phase 3, 155 Phase 4, 90 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable602Completed 277, Unknown 125, Recruiting 78, Not yet recruiting 45, Terminated 44, Withdrawn 15, Active not recruiting 8, Enrolling by invitation 5, Suspended 5
Phase 2295Completed 142, Unknown 52, Terminated 41, Recruiting 24, Withdrawn 22, Not yet recruiting 8, Active not recruiting 5, Suspended 1
Phase 3232Completed 118, Unknown 37, Terminated 26, Recruiting 20, Withdrawn 12, Not yet recruiting 11, Active not recruiting 4, Suspended 4
Phase 4155Completed 72, Recruiting 26, Unknown 25, Terminated 15, Not yet recruiting 8, Withdrawn 8, Active not recruiting 1
Phase 190Completed 48, Terminated 11, Unknown 11, Recruiting 7, Not yet recruiting 6, Withdrawn 4, Active not recruiting 3
Early Phase 16Completed 2, Recruiting 2, Active not recruiting 1, Terminated 1

Follow Shock: new trials by email Literature Review of Shock trials Research Report on Shock

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Validation of the iCVS Model in Patients Admitted to the Intensive Care Unit
Shock
Not yet recruitingMeir Medical Center11502028-04-012026-10-09
Extended vs. Intermittent Meropenem Infusion in Sepsis Patients in the ICU
Extended beta-lactam antibiotics, Intermittent Beta-lactam antibiotics - Sepsis, Septic Shock
Not yet recruitingAssiut University902027-10-012026-09-01
Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulopathy
• Sivelestat intravenous infusion, NaCl intravenous infusion - Septic Shock, Coagulopathy
Phase 2Not yet recruitingUniversity Hospital, Strasbourg, France1202027-08-012026-08-20
A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent
Normal Saline, Centhaquine - Hypovolemic Shock
Phase 3Not yet recruitingPharmazz, Inc.4302027-02-012026-09-17
Biological Effects of Hemoadsorption in Septic Shock
Hemoadsorption cartridge - Septic Shock, Vasopressor Resistance, Multiple Organ Dysfunction
Not applicableNot yet recruitingMiguel Sanchez Garcia162027-01-072026-07-20
Remote Ischemic Postconditioning in Septic Shock
Remote ischemic conditioning, No intervention - Adult Patients With Septic Shock Admitted in Intensive Care Unit
Not applicableNot yet recruitingHospices Civils de Lyon7202027-01-012026-10-09
SWedish Intensive Care Biobank
Any Condition Underlying Critical Illness
Not yet recruitingUppsala University250002027-01-012026-05-13
Immune Dysregulation During Sepsis: A Natural History Cohort
Sepsis, Septic Shock
Not yet recruitingNational Heart, Lung, and Blood Institute (NHLBI)5002027-01-012026-10-09
French Observatory on the Management of Cardiogenic Shock 2
Cardiogenic Shock
Not yet recruitingFrench Cardiology Society10002027-01-012026-10-09
Hong Kong Cardiogenic Shock Initiative
Cardiogenic Shock Acute, STEMI - ST Elevation Myocardial Infarction
Not yet recruitingPrince of Wales Hospital, Shatin, Hong Kong3202026-12-012026-09-16
Capillary Refill Time Variation to Predict Oxygen Comsumption Variation After FLuid Challenge (CARTOFL)
Indirect calorimetry measurement - Critically Ill Patients, Circulatory Shock
Not yet recruitingHospices Civils de Lyon802026-12-012026-09-24
Alveolar Dead Space as Predictor of Organ Failure in Severe Sepsis
Sepsis, Severe Sepsis
Not yet recruitingThe University of Texas Health Science Center, Houston302026-12-012025-06-11
RPM Signals in Outpatient CAR T Therapy
Cytokine Release Syndrome, Immune Effector Cell-Associated Neurotoxicity Syndrome
Not yet recruitingCurrent Health1252026-12-012026-10-20
CLL-1/CD70 Dual-Target CAR-T Cell Therapy for Acute Myeloid Leukemia
CLL-1-CD70 CAR-T Cell Injection - Acute Myeloid Leukemia (AML), Relapsed/Refractory Acute Myeloid Leukemia
Phase 1Not yet recruitingLiping Dou122026-11-302026-10-27
FOUR-Based Modification of ICU Severity Scores
ICU Mortality (Survival Rate)
Not yet recruitingAl-Nahrain University20002026-11-012026-09-22
Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells - Intensive Care Unit
13C6-Glucose - Glucose, Metabolism
Not applicableNot yet recruitingVanderbilt University Medical Center252026-11-012026-09-09
Core-to-Big-Toe Temperature Gradient as a Marker of Peripheral Perfusion in Adult Patients With Septic Shock
Septic Shock, Sepsis
Not yet recruitingAssiut University542026-11-012026-10-13
Clinical Performance Study of Microbio InfectID-BSI for Detection of Bacteria and Yeast With Patient Blood Samples
InfectID-BSI (Bloodstream Infection) qPCR Assay - Bloodstream Infection, Sepsis
Not yet recruitingMicrobio Co Ltd15002026-11-012026-10-08
Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock
Angiotensin II, Norepinephrine - Septic Shock
Phase 4Not yet recruitingWake Forest University Health Sciences782026-11-012026-09-24
Low Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With Tebentafusp
Dexamethasone - Uveal Melanoma, Metastatic
Phase 2Not yet recruitingUniversity of California, San Diego342026-11-012026-09-03

Showing 20 of 2234. Sign in to see all of them.

Narrower conditions

Shock, Septic (1060)  ·  Sepsis (680)  ·  Shock, Cardiogenic (289)  ·  Systemic Inflammatory Response Syndrome (195)  ·  Multiple Organ Failure (190)  ·  Cytokine Release Syndrome (162)  ·  Critical Illness (151)  ·  Acute Kidney Injury (107)  ·  COVID-19 (103)  ·  Wounds and Injuries (82)  ·  Shock, Hemorrhagic (79)  ·  Respiratory Distress Syndrome (77)  ·  Heart Failure (67)  ·  Inflammation (64)

Broader conditions

Pathological Conditions, Signs and Symptoms (2233)  ·  Pathologic Processes (2219)  ·  Inflammation (1403)  ·  Infections (1273)  ·  Systemic Inflammatory Response Syndrome (1260)  ·  Sepsis (519)  ·  Cardiovascular Diseases (497)  ·  Vascular Diseases (434)  ·  Heart Diseases (385)  ·  Myocardial Ischemia (303)  ·  Necrosis (294)  ·  Infarction (293)  ·  Ischemia (293)  ·  Myocardial Infarction (259)

Interventions

Saline Solution (65)  ·  Norepinephrine (50)  ·  Standard of Care (47)  ·  Sodium Chloride (41)  ·  Hydrocortisone (39)  ·  Blood Specimen Collection (37)  ·  Ascorbic Acid (32)  ·  Vasopressins (24)  ·  Thiamine (21)  ·  Ringer's Lactate (20)  ·  Albumins (19)  ·  Echocardiography (19)  ·  tocilizumab (16)  ·  Dexmedetomidine (15)  ·  esmolol (15)

Sponsors

Assistance Publique - Hôpitaux de Paris (54)  ·  Assiut University (34)  ·  Hospices Civils de Lyon (24)  ·  Southeast University, China (23)  ·  Central Hospital, Nancy, France (21)  ·  Ain Shams University (19)  ·  University Hospital, Strasbourg, France (18)  ·  Cairo University (17)  ·  Centre Hospitalier Universitaire de Nīmes (17)  ·  Centre Hospitalier Universitaire, Amiens (16)  ·  Mahidol University (16)  ·  National Taiwan University Hospital (16)  ·  University Hospital, Montpellier (15)  ·  Beth Israel Deaconess Medical Center (14)  ·  Copenhagen University Hospital, Rigshospitalet (14)

Countries

United States (397)  ·  France (366)  ·  China (174)  ·  Germany (140)  ·  Egypt (98)  ·  Italy (97)  ·  Canada (91)  ·  Spain (73)  ·  Netherlands (66)  ·  United Kingdom (54)  ·  Brazil (52)  ·  Denmark (51)  ·  Turkey (Türkiye) (49)  ·  Belgium (46)  ·  Switzerland (43)

Top investigators

Andrea Morelli, MD (7)  ·  Anders Perner, MD, PhD (4)  ·  Holger Thiele, MD (4)  ·  Michael W Donnino, MD (4)  ·  Ahmed Mukhtar, Professor (3)  ·  Alan E Jones, MD (3)  ·  Anand Kumar, MD (3)  ·  Carsten Skurk, MD (3)  ·  Djillali Annane, MD (3)  ·  Djillali Annane, MD, PhD (3)  ·  Eric Bellissant, MD, PhD (3)  ·  Jason Sperry, MD (3)

Results publications

PMID 26903338, PMID 28101605, PMID 34519356, PMID 36416787, PMID 11794169, PMID 28343448, PMID 34605781, PMID 11445675, PMID 18305265, PMID 19531784, PMID 21516036, PMID 23353941, PMID 23899564, PMID 25392034, PMID 29784057, PMID 32192578, PMID 32520577, PMID 39716214, PMID 10470572, PMID 11395904, PMID 11588440, PMID 12500513, PMID 12519925, PMID 12720570, PMID 12794416, PMID 15276536, PMID 16134766, PMID 16424713, PMID 16497588, PMID 16855261, PMID 17334251, PMID 17638928, PMID 18090355, PMID 18375483, PMID 18434884, PMID 18533029, PMID 18702960, PMID 19926252, PMID 20179283, PMID 20802500, PMID 21615299, PMID 21669950, PMID 21918497, PMID 22073193, PMID 22110166, PMID 22704255, PMID 22751621, PMID 22920912, PMID 23001587, PMID 23067578

NIH funding

2014 (8), 2018 (8), 2017 (6), 2023 (6), 2019 (5), 2005 (3), 2015 (3), 2025 (3), U01HL077863 (3), 2009 (2), 2016 (2), M01RR002558 (2), U54GM062119 (2), 1RC3GM093717-01 (1), 1UG3HL157401-01A1 (1)